Oil drops, Brent crude falls below $100 as China lockdowns spark demand fears

Oil drops, Brent crude falls below 0 as China lockdowns spark demand fears


Oil pumping rigs are situated next to a vineyard of table grapes as viewed on July 8, 2021, north of Bakersfield, California.

George Rose | Getty Images

Oil prices slid Monday, accelerating two straight weeks of declines as lockdowns in China sparked demand fears.

International benchmark Brent crude declined 3.9%, or $4.02, to trade at $98.72 per barrel. West Texas Intermediate crude futures, the U.S. oil benchmark, shed $3.95, or 4%, to trade at $94.33 per barrel.

“The spread of Covid in China is the most bearish item affecting the market,” said Andy Lipow, president at Lipow Oil Associates. “If [Covid] spreads throughout China resulting in a significant number of lockdowns, the impact on oil markets could be substantial.”

China is the world’s largest oil importer, and the Shanghai area consumes roughly 4% of the country’s crude, according to Lipow.

The potential hit to demand comes as the supply side of the equation has been front and center given Russia’s role as a key oil and gas producer and exporter.

Last week the International Energy Agency announced that its member countries would release 120 million barrels from emergency stockpiles, of which 60 million barrels would be from the U.S. The announcement followed the Biden administration saying it would release 180 million barrels from the Strategic Petroleum Reserve in an effort to alleviate soaring prices.

WTI fell 1% last week while Brent declined 1.5%, with both contracts posting their fourth negative week in the last five.

Oil prices have been on a roller-coaster ride since Russia invaded Ukraine. WTI briefly traded as high as $130.50 on March 7, the highest level since July 2008. The contract has fallen nearly 30% since. Brent meantime spiked to $139.13 in March.

Part of the move is thanks to fears over what a disruption in Russian supply would mean for an already tight market. The IEA previously predicted that three million barrels per day of Russian oil output was at risk.

Traders also attributed oil’s wild swings to non-energy market participants exchanging contracts as a way to hedge against inflation, among other things.

Still, Wall Street firms were quick to point out that tapping emergency oil stockpiles will alleviate the price spike in the near-term, but doesn’t address the fundamental issues in the market.

“[S]ome of the market tightness caused by the self-sanctioning of Russian crude buyers — either in fear of future sanctions or for reputational reasons — should ease,” UBS wrote in regards to the emergency releases.

“But it will not fix the the oil market’s structural imbalance resulting from years of underinvestment at a time of recovering global demand,” the firm added.



Source

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals
Business

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

Food and Drug Administration Commissioner Marty Makary warned that the U.S. is falling behind China in early-stage drug development and called for reforms that could streamline the process for starting trials on new treatments.  In an interview with CNBC on Wednesday, Makary specifically pointed to three bottlenecks that he said cause the U.S. to fall […]

Read More
Seattle Seahawks begin sale process after Super Bowl win
Business

Seattle Seahawks begin sale process after Super Bowl win

Dareke Young #83 of the Seattle Seahawks celebrates with teammates during the third quarter of the NFC Championship game against the Los Angeles Rams at Lumen Field on Jan. 25, 2026 in Seattle, Washington. Jane Gershovich | Getty Images The Seattle Seahawks are officially up for sale. The NFL team, which defeated the New England […]

Read More
FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive
Business

FDA chief Marty Makary says ‘everything should be over the counter’ unless drug is unsafe or addictive

Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring – doubling down on a push that some in the pharmaceutical industry have questioned.  In an interview Wednesday in Washington, D.C., Makary said the FDA aims to make […]

Read More